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Background: The clinical prediction of survival is among the most challenging tasks because it refers to the process
whereby the medical team assimilates clinical data using subjective methods. The purpose of this prospective
observational study was to develop a model for evaluating survival time using objective laboratory parameters.
Methods: Albumin (ALB), creatinine (CRE), C-reactive protein (CRP) and the neutrophilic leukocyte count (NEU) were
measured using automated analysers. A total of 177 subjects with any one positive item of 4 items were included in
the study. Age on the observation date and date of death were recorded.
Results: ALB, CRE, CRP and the NEU were all significant predictors of survival time (p < 0.05). The median survival time
of patients with anyone of the 4 items positive would be over 1 year; if any 2 items were positive, the median survival
time was approximately 1 year; if any 3 items were positive, the median survival time was approximately 4 months and
if 4 items were positive, the median survival time was approximately 20 days.
Conclusions: This study suggests that a model using ALB, CRE, CRP and the NEU is potentially useful in the objective
evaluation of survival time in terminally ill patients.
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The clinical prediction of survival in patients has the poten-
tial for significant impact on a variety of treatment decisions.
Correct survival estimates can help to prevent inappropriate
therapies, thereby improving the quality of end-of-life care.
In addition, the ability to determine an accurate prognosis
can have a major impact on supportive care for patients and
their families and can facilitate timely referral for hospice
care. The ability to determine prognosis is also important
for the direction of research programmes and for the priori-
tisation of health care resources.
The clinical prediction of survival is among the most
challenging tasks that a physician can face [1-3]. It refers
to the process whereby the medical team assimilates
clinical data using informal and subjective methods* Correspondence: liuhui60@sina.com
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unless otherwise stated.[4-6]. The nature of this approach tends to preclude pre-
cise specification.
Modern medicine, particularly medical research, re-
quires a reliance on objective laboratory testing rather
than experience and judgment alone for the diagnosis of
disease. Laboratory test indicators have sensitive, accurate
and quantitative characteristics. In addition to their ability
to provide a reliable and objective basis for screening and
diagnosis, they can also measure disease severity [7-9].
Therefore, nonspecific changes in laboratory parameters
in terminally ill patients could be considered key prognos-
tic factors in the evaluation of survival prediction in these
patients. A recent study on this topic involves in bio-
marker profiling by nuclear magnetic resonance spectros-
copy for the prediction of all-cause mortality [10]. Our
study was designed to perform a quantitative analysis on
changes in routine laboratory parameters and, further-
more, to explore an effective model for the evaluation of. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Correlations between survival time and laboratory
parameters
Item r p Item r p
NEU −0.422 <0.0001 ALB 0.455 <0.0001
LYM 0.234 <0.0001 AST −0.308 <0.0001
RBC 0.104 0.081 CRE −0.028 0.643
HB 0.186 0.002 CRP −0.397 <0.0001
PLT 0.107 0.073 - - -
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ically responsive in the terminally ill. It is potentially pos-
sible to provide a more simple and precise method for the
prediction of survival time in clinical application.
Subjects and methods
Subjects
The subjects were collected in five batches from five
hospitals (First Hospital of Dalian Medical University;
Second Hospital of Dalian Medical University; Central
Hospital of Dalian; Hospital of Dalian University; Third
Hospital of Dalian) in the city of Dalian, China, from
May 2010 to May 2012. A total of 283 subjects were in-
cluded in the study (155 males, 128 females; mean age
65.7 ± 14.2 years), of whom 156 were selected in an in-
tensive care unit and 127 were selected on the ward. The
beginning of observation was at collection of the blood
sample. Age on the observation date and medical record
number were recorded to examine more information be-
fore follow up; date of death or survival status was recorded
after one year. The data regarding death and survival were
obtained from the medical records and residence queries.
Subjects who were lost to follow up were recorded as cen-
sored cases.
The experiments were conducted in accordance with
the Declaration of Helsinki. The blood samples taken
were part of the usual care of the subjects and were not
taken for research purposes alone. The Institutional Eth-
ics Committee of Dalian Medical University approved
the study and waived the need for written informed con-
sent from the participants due to the observational na-
ture of the study.
Blood sampling and blood analyses
Blood was drawn from the antecubital vein at 07.00 am into
two vacuum tubes; one tube contained an anticoagulant
and was used for blood cell counts, and the other was used
for the determination of biochemical indices. Measurement
of biochemical parameters, which included albumin (ALB,
40-55 g/L), aspartate aminotransferase (AST, <40 U/L) and
creatinine (CRE, 45-105 μmol/L), was performed using
an automatic biochemistry analyser (Hitachi7600-110). The
level of high-sensitivity C-reactive protein (CRP, <8.2 mg/L)
was determined by nephelometry, which involved perform-
ing a latex particle-enhanced immunoassay using a Beck-
man Access IMMAGE Immunochemistry System. The
assay was sensitive enough to detect 0.02 mg/L of serum
CRP. Measurement of blood cell counts, which included
neutrophilic leukocyte (NEU, 3.5-9.5 × 109/L), lymphocyte
(LYM, 1.1-3.2 × 109/L), red blood cell (RBC, 3.8-5.8 ×
1012/L), platelet (PLT, 125-350 × 109/L), and haematoglobin
(HB, 115-175 g/L) were determined using an automated
haematology analyser (Sysmex 2100; Japan). The experimen-
tal investigations were performed in the clinical laboratoryof our University Hospital, using standard commercial
reagent kits.
Statistical analysis and establishment of the model
The relationships of survival time with laboratory parame-
ters were assessed by Spearman correlation. Cox regression
analysis was used to assess the dead risk from laboratory
parameters and was weighted by age (alpha = 0.05, two-
tailed test).
The model for evaluating survival time was created using
life table analysis. Prior to analysis, the abovementioned in-
dicators were transformed into qualitative indicators based
on the reference ranges; values above the upper limit were
designated as positive for AST, CRE, CRP and NEU, and
values below the lower limit were designated as positive for
ALB, LYM, RBC, HB, PLT. The calculations were performed
using SPSS software for Windows (Chicago, IL, USA).
Results
Correlations of survival time with laboratory parameters
are shown in Table 1. ALB, CRP, LYM and NEU were
chosen as predictors of survival time according to correl-
ation coefficient. The 223 subjects with anyone positive
item of these 4 items were allowed to enter the prospect-
ive observational study. Cox regression analysis was used
to assess the predictors, as shown in Table 2. The LYM
were not significant predictors of survival time (p > 0.05).
ALB, NEU, CRP and CRE were chosen as predictors of
survival time according to correlation coefficient as well as
mechanisms. The 177 subjects with anyone positive item of
4 items (ALB, CRE, CRP and NEU) were allowed to enter
the prospective observational study. Cox regression analysis
revealed that ALB, NEU, CRP and the CRE were all signifi-
cant predictors of survival time (p < 0.05), as shown in
Table 3. The levels of ALB, NEU, CRP and CRE in different
dead time are shown in Table 4.
A total of 177 subjects were included in this study (114
males and 63 females; mean age 66.5 ± 13.6 years). The
main diseases were cardiovascular and cerebrovascular dis-
ease (20.3%), chronic obstructive pulmonary disease (9.6%),
various types of tumours (44.1%) and other diseases not in-
cluding accidental injuries (26.0%). After one year, a total of
93 subjects died including 27 patients with cardiovascular
Table 2 Cox regression analysis of dead risk from laboratory
parameters (ALB, CRP, LYM and NEU)
Item B SE p Exp (B) 95% CI for Exp (B)
ALB −0.101 0.030 0.001 0.904 0.852~0.958
CRP 0.011 0.005 0.018 1.011 1.002~1.020
LYM −0.184 0.202 0.363 0.832 0.560~1.236
NEU 0.159 0.037 <0.0001 1.172 1.091~1.259





Quartile (25th, 50th, 75th)
ALB CRE CRP NEU
0~ 25.3, 29.8, 34.4 72.3, 115.1, 190.5 6.7, 19.6, 27.0 5.3, 8.7, 13.3
90~ 32.3, 33.3, 35.1 63.9, 83.3, 130.3 5.0, 29.7, 58.8 3.9, 5.4, 9.2
180~ 31.2, 34.4, 37.7 77.5, 87.3, 95.8 4.4, 24.3, 57.8 2.7, 3.7, 7.3
270~ 26.3,32.7, 39.4 80.0, 106.9, 134.7 1.5, 3.2, 47.1 3.8, 8.5, 9.3
>360 32.5, 35.7, 39.6 84.8, 107.6, 120.8 1.3, 4.8, 15.1 3.1, 4.5, 6.4
Table 5 The original data and establishment of a predictive




Number (death + censored) Total
number1+ 2+ 3+ 4+
0~ 6 + 0 10 + 0 7 + 0 13 + 0 36
30~ 2 + 0 2 + 0 2 + 0 1 + 0 7
60~ 4 + 0 1 + 0 2 + 0 1 + 0 8
90~ 3 + 0 4 + 0 1 + 0 0 + 0 8
120~ 0 + 0 2 + 0 0 + 0 0 + 0 2
150~ 1 + 0 1 + 0 0 + 0 0 + 0 2
180~ 1 + 0 1 + 0 0 + 0 0 + 0 2
210~ 0 + 0 0 + 0 0 + 0 0 + 0 0
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obstructive pulmonary disease (6.5%), 46 patients with vari-
ous types of tumours (49.5%) and 14 patients with other
diseases (15.0%).
Table 5 presents the establishment of a predictive model
of the survival time of critically ill patients and an analysis of
the results. The median survival times of patients with one,
two, three or four (all) positive laboratory indicators were as
follows: one, over 360 day; two, 328.9 days (approximately
1 year); three, 120.0 days (approximately 4 months); and
four, 19.6 days. There was a significant difference in the sur-
vival times of patients with one, two, three or four of four
positive items, as shown in Figure 1.
Discussion
The hypothesis for this study was that any test results
related to death are likely occur within one year of death
and are unlikely to be related to a death occurring after
one year. Therefore, we conducted a one-year prospect-
ive observational study in a group of critically ill patients
based on blood parameters.
For the routine laboratory test indicators, the research
basis are usually solid and under the good quality control;
hence, the prognostic value of routine clinical and bio-
chemical parameters was evaluated in this study. ALB,
CRP, LYM and NEU should be chosen as predictors of
survival time according to correlation coefficient; however,
these 4 items were considered as an integer for assessment
using cox regression analysis, the LYM showed no signifi-
cance as determined by a p value = 0.363; whereby other
parameters should be selected for the analysis.
Natural death for the majority people can be considered
as a process of loss of organ function. Blood biochemical
studies are used in the assessment of organ function. TheTable 3 Cox regression analysis of dead risk from laboratory
parameters (ALB, CRE, CRP and NEU)
Item B SE p Exp (B) 95% CI for Exp (B)
ALB −0.091 0.032 0.005 0.913 0.857~0.972
CRE 0.003 0.001 0.031 1.003 1.000~1.005
CRP 0.010 0.005 0.028 1.010 1.001~1.019
NEU 0.135 0.036 <0.0001 1.145 1.067~1.228identification of blood laboratory parameters in terminally
ill patients is essential to our understanding of the impair-
ment and restorative processes that occur during the end
of life and the functional consequences of hypoergia.
Therefore CRE, which reflects renal function, was chosen
as a predictor in spite of relative small correlation coeffi-
cient of CRE.
The laboratory parameters that appeared responsive to
death included ALB, CRE, CRP and the NEU, and the
trend of the response was consistent with the patho-
logical changes [11-13]. Therefore, these laboratory pa-
rameters can be considered a quantitative evaluation of
holistic function. Cox regression analysis revealed that
ALB, NEU, CRP and the CRE were all significant predic-
tors of survival time (p < 0.05).
The critically ill patients in this study had been diag-
nosed with tumours, cardiovascular and cerebrovascular240~ 1 + 0 3 + 0 0 + 0 0 + 0 4
270~ 3 + 9 0 + 1 0 + 0 0 + 0 13
300~ 2 + 0 2 + 0 0 + 0 0 + 0 4
330~ 2 + 0 2 + 0 3 + 0 0 + 0 7
>360 0 + 50 0 + 23 0 + 9 0 + 2 84
Total 25 + 59 = 84 28 + 24 = 52 15 + 9 = 24 15 + 2 = 17 177
MST (days) >360.0 328.9 120.0 19.6 -
Patients with one (1+), two (2+), three (3+) or four (4+) positive laboratory
indicators among ALB, CRE, CRP and NEU.






















Figure 1 Difference in survival times of patients with one (1+),
two (2+), three (3+) or four (4+) positive laboratory indicators
among ALB, CRE, CRP and NEU.
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China, these three diseases account for over 70% of all-
cause mortality [14], and they accounted for 74% (131/
177) of disease in this observational group and 85% (79/
93) of disease in dead subjects. Although the different
types and severity of disease as well as ageing may affect
survival times, we believe that laboratory parameters can
reflect the relation of these factors with survival time,
thus simplifying complex issues. The results from this
study demonstrate significant changes in 4 laboratory in-
dicators. These findings are consistent with our previous
study [7-9], indicating that these laboratory parameters
could have potential in the prediction of survival in crit-
ically ill patients.
ALB reflects liver function, CRE reflects renal func-
tion, and CRP and the NEU reflect systemic inflamma-
tion. Abnormal changes in two or more indicators can
be considered as nonspecific systemic changes, which
are associated with death, whereas abnormal changes in
a single indicator may be specific. We transformed the
measurement data into qualitative data by taking the
upper or lower limit of the reference range for each indi-
cator as the cutoff value. As data transformation was
conducted according to the reference range of each item,
theoretically, the reference range was determined by
95% of the population. Therefore, the positivity rate in
the normal population was less than 5% in a single
index. According to the combination principle, the prob-
ability of a normal individual with two or more positive
factors among the 4 laboratory indicators is rare,
whereas the positivity rate for any one of four items istheoretically 5% × 4 = 20% in a healthy population and
may be not related to the frequency of mortality. There-
fore, subjects with only one positive indictor were in-
cluded as control group and patients who demonstrated
two or more two positive laboratory indicators were in-
cluded as observed groups.
The results indicate that if a patient presents any 1 of 4
items as positive, the expected survival time (50% survival
probability) will be over 1 year; if any 2 items are positive,
the expected survival time will be approximately 1 year
(328.9 days); if any 3 items are positive, the expected sur-
vival time will be approximately 4 months (120.0 days);
and if 4 items are positive, the expected survival time will
be approximately 20 days. This study suggests that a
model using ALB, CRE, CRP and the NEU is potentially
useful in the objective evaluation of survival time in ter-
minally ill patients.
Although the accurate prediction of survival is essen-
tial for palliative care and several clinical tools predicting
survival time exist [15-17], these approaches are not
considered appropriate [18]. This largely reflects the di-
verse and complex causes of death. Clearly, our findings
are helpful for the establishment of a model using bio-
markers to improve survival prediction. Further studies
are warranted to develop a more available model for the
accurate prediction of survival with routine laboratory
parameters.
Conclusions
Despite the complex causes of death, our results empha-
sise that ALB, CRE, CRP and the NEU may reflect the
relation of these complex factors with survival times and
could be considered as key prognostic factors. A model
without complex mathematical calculation should be
suggested for predicting survival time based on these
routine laboratory parameters.
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